🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06687122
Recruiting Not applicable

Egg Intake, Metabolic Outcomes and Choline Levels

NCT06687122 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-01-24
Last updated
2026-05-12

Condition(s) studied

Obesity and Obesity-related Medical Conditions

Investigational drug(s) / intervention(s)

3 whole eggs

3 whole eggs: Participants will be free-living and will not be supplied with any other food except for the eggs during the intervention period with no restrictions of energy intake.

Study summary

The purpose of this research is to determine the effect of additional daily egg intake on metabolic phenotypes and metabolism in the context of obesity.

Eligibility

Sex
ALL
Min age
30 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Male or female participant of any race or ethnicity between 30-65 (inclusive) years of age * BMI \> 30 kg/m2 * Non-smoker * Willing to consume 3 eggs per day for one dietary period of 4 weeks * Willing to avoid eggs during the rest of the study except for eggs that are provided * Willing to follow the study protocol including maintaining usual lifestyle during the entire study Exclusion Criteria: * Age \< 30 or \> 65 years * BMI \< 30 kg/m2 * Vegans or individuals who do not consume eggs * Individuals who are currently pregnant or planning to become pregnant during the course of the study; or are currently breastfeeding * Smokers, users of recreational drugs * Individuals taking antibiotics or natural health products including prebiotics or probiotics

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Research Center of the Institut universitaire de cardiologie et de pneumologie de Québec - ULaval Québec Quebec Recruiting

More University of Guelph trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06687122 on ClinicalTrials.gov ↗ ← All trials in Canada